Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease - Wikidata - wikimedia - TriplyDB

Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease

Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease

http://www.wikidata.org/entity/Q37059538

about

Asthma in sickle cell disease: implications for treatment.Placenta growth factor-induced early growth response 1 (Egr-1) regulates hypoxia-inducible factor-1alpha (HIF-1alpha) in endothelial cells.Acute chest syndrome: sickle cell disease.Asthma morbidity and treatment in children with sickle cell disease.Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.Inflammatory targets of therapy in sickle cell disease.Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13.Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease Role of biomarkers in understanding and treating children with asthma: towards personalized care.Asthma management in sickle cell disease Leukotriene pathway in sickle cell disease: a potential target for directed therapy.Leukotrienes and sex: strange bedfellows?Placental growth factor: What hematologists need to know.Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment.Placenta growth factor mediated gene regulation in sickle cell disease.Airway inflammation in sickle cell disease-A translational perspective.Airway hyperreactivity is frequent in non-asthmatic children with sickle cell disease.The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.

P2860

Q33872120-9D4E3F19-8971-4D0C-9460-DCC1F8442933 Q33966992-87CE3BE6-139D-4FB8-8717-2EDE01A8B94D Q34187526-5E085BA6-A977-4F22-A1F6-C3E201FF508F Q35599687-D1866927-E916-40CF-AEC1-B2A0ECADE300 Q35672817-C1A9F818-0119-479D-826B-5F7799100607 Q36385224-4B3BAF11-88BB-4590-9109-7F77B15914F6 Q36515104-1ACF0B54-F0E1-4FD9-86E5-11AE60B72738 Q37082000-CF9A061A-DCD8-41F9-B932-28C9C9817AE7 Q37140629-AAC5F034-CDA7-4DA5-ACED-7DFB9357C9B3 Q37346672-63FA65AC-C152-4259-930E-605B771B9F77 Q37810108-5C4E8980-5D73-4140-A86F-4649D8A18EBC Q38652803-266D5BE5-6489-4828-BD15-AE62D77C0F87 Q38823169-67BFDFB5-F338-4E29-8D41-79DF5A0B38AB Q40758763-3DA28B8B-0715-4B24-8BE2-2ABB22FF6F7D Q46063095-771E5898-BCEB-4A42-8897-07DE3AFF8E60 Q47647345-C040EDB4-121A-4C85-9F1B-A2C1DFECB2A4 Q48892688-6C79D469-B5FB-4FE5-A16C-6B6C4E9FD6A7 Q50133441-DC3F11FB-BAB6-426C-B348-91EB0D1EDEDD

P2860

Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease

http://www.wikidata.org/entity/Q37059538

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Elevated urinary leukotriene E ...... ldren with sickle cell disease

@en

Elevated urinary leukotriene E ...... dren with sickle cell disease.

@nl

type

label

Elevated urinary leukotriene E ...... ldren with sickle cell disease

@en

Elevated urinary leukotriene E ...... dren with sickle cell disease.

@nl

prefLabel

Elevated urinary leukotriene E ...... ldren with sickle cell disease

@en

Elevated urinary leukotriene E ...... dren with sickle cell disease.

@nl

P1433

Q37059538-951CACD9-018A-4937-A49C-96668780ADCD

P1476

Q37059538-F5E24737-B895-48CF-8A22-9B71B72BEBA2

P2093

Q37059538-0D05ACCD-B395-4D51-9EDD-456709C6529A

Q37059538-0E4A558F-ED72-4921-A94E-1608CCC28100

Q37059538-45D74834-E1A4-4747-929F-E7F5591BD74F

Q37059538-8D3CC840-2DCF-4277-95B9-824273FDB08A

Q37059538-ADC65CFC-C032-4666-B2B5-CE1B4DA7B069

Q37059538-C866AFE4-79AD-4640-865A-FEBCBA9FAAF7

Q37059538-D61A0D5F-3371-44C4-AC85-B09CE4788F88

Q37059538-F2162726-EE0A-4ACB-A330-BCAD537A91DF

P2860

Q37059538-0635CA7F-3BAF-4C36-AA85-469E0A36241C

Q37059538-0CF531FB-9AEA-4BD5-BC81-E5116C550C47

Q37059538-16C1D840-777C-4C23-AAF9-3E2A02CC1A14

Q37059538-19F28C43-D355-41B8-A3A0-8E6D4CB6C01C

Q37059538-3A48BC67-08C8-48EF-ABF9-0930F46105C9

Q37059538-545B1C1E-62F9-4214-993E-6E6CD6A36707

Q37059538-5EED5C9E-A7D6-4D1C-BB45-AEEAB0F6C16E

Q37059538-607743F1-7C06-4A7B-96CC-A0758416A1F1

Q37059538-616346ED-69EE-4CFB-81BE-9F51243F9339

Q37059538-6FD9D83F-1694-4753-B4CB-76D7970EDB70

P304

Q37059538-EBD3759B-8DDE-424A-818F-57653207B143

P31

Q37059538-A2E48DCF-2F3F-4C62-9325-397B8F1D2055

P356

Q37059538-AF8F953F-64E7-4576-9591-86F57D98C120

P433

Q37059538-BD7079DE-AE27-440F-AE50-7815492AFAC0

P478

Q37059538-3BAD570E-85D0-4BC7-A2B4-0DE69CBED8C0

P577

Q37059538-8600F6FC-230F-44D8-BED8-4021C3775D61

P5875

Q37059538-FAF1E95C-7846-467C-B644-9F4F501C1B86

P698

Q37059538-78143FFD-FC57-46D2-9EFD-0EA7A225D877

P921

Q37059538-208CA575-CFC9-410F-B0FA-3450866051B5

Q37059538-9944F0C3-72EC-4F21-B65E-BAE04A624E6A

P932

Q37059538-0DDD0809-5498-4412-8359-E8F89491D402

P356

P1433

American Journal of Hematology

P1476

Elevated urinary leukotriene E ...... ldren with sickle cell disease

@en

P2093

Jeanine E Jennings

http://www.w3.org/2001/XMLSchema#string

Jessica Boyd

http://www.w3.org/2001/XMLSchema#string

Jingnan Mao

http://www.w3.org/2001/XMLSchema#string

Joshua J Field

http://www.w3.org/2001/XMLSchema#string

Mario Castro

http://www.w3.org/2001/XMLSchema#string

Michael R DeBaun

http://www.w3.org/2001/XMLSchema#string

Robert C Strunk

http://www.w3.org/2001/XMLSchema#string

Thiruvamoor Ramkumar

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the human cysteinyl leukotriene CysLT1 receptor

The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor

Association between asthma, asthma symptoms and C-reactive protein in US adults: data from the National Health and Nutrition Examination Survey, 1999-2002.

Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.

Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.

Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Recent advances in asthma genetics.

Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses.

P304

640-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.21199

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5343642

http://www.w3.org/2001/XMLSchema#string

P698

18506703

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

hospitalization

P932

3729258

http://www.w3.org/2001/XMLSchema#string